DENISE GOODMAN: Open Payments
NPI 1730449505 · UNION CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 59 payments from 12 companies in 2025. Trend: 2023 $653 · 2024 $1,030 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $220 |
| Otsuka America Pharmaceutical, Inc. | 13 | $188 |
| Ardelyx, Inc. | 6 | $108 |
| AKEBIA THERAPEUTICS INC | 5 | $89 |
| Calliditas Therapeutics US Inc. | 4 | $87 |
| Fresenius USA Marketing, Inc. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Travere Therapeutics, Inc. | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| OPKO Pharmaceuticals, LLC | 3 | $45 |
Products named: Kerendia, JYNARQUE, IBSRELA, TARPEYO, VELPHORO, FARXIGA, Auryxia, RAYALDEE.
Industry payments across NJ — which companies pay providers there.
